S80046
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 上海源葉生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2024/7/2 20:20:57
- 訪問次數(shù) 196
聯(lián)系方式:何小姐15921386130 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,,謝謝!
- 提示:詳情請(qǐng)下載說明書。
- 產(chǎn)品描述: YK-4-279 blocks RNA Helicase A (RHA) binding with EWS-FLI1 (oncogenic protein). YK-4-279 induces apoptosis and shows anti-proliferation activities towards various cancer cells. YK-4-279 has a chiral center and it can be separated into two enantiomers. YK-4-279 can be used for the research of cancer
- 靶點(diǎn): IC50: 0.94 µM (TC32), 1.83 µM (TC71), 1.03 µM (RDES), 0.33 µM (SKES), 0.94 µM (MMH-ES-1), 0.60 µM (STA-ET 7.2), 1.46 µM (A4573), 4.95 µM (PC3), 22.82 µM ( MCF7), 0.82 µM (MDA-MB-231), 1.514 µM (PANC1), 14.28 µM (ASPC1)
- 體內(nèi)研究: YK-4-279 (1.5 mg; i.p. once) inhibited ESFT tumor growth
- 參考文獻(xiàn):
1. Erkizan HV, et al. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nat Med. 2009 Jul;15(7):750-6. 2. Barber-Rotenberg JS, et al. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget. 2012 Feb;3(2):172-82.
- 溶解度: DMSO : 25 mg/mL (68.27 mM; Need ultrasonic)
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.731 ml 13.654 ml 27.307 ml 5 mM 0.546 ml 2.731 ml 5.461 ml 10 mM 0.273 ml 1.365 ml 2.731 ml 50 mM 0.055 ml 0.273 ml 0.546 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,,我司不保證所提供信息的性,,僅供客戶參考交流研究之用。